Amgen To Present At The Morgan Stanley Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Baird 'Incrementally Positive' on Amgen's (AMGN) Initial AMG 420 results
September 10, 2018 12:01 PM EDTBaird analyst Brian Skorney is incrementally positive on Amgen's (NASDAQ: AMGN) initial AMG 420 results.
"We think the very first clinical results for Amgen's anti-BCMA BiTE look very promising and competitive with those of the CART approach (CELG/BLUE/JNJ)," Skorney said. "We... More
